If you were implanted with a Covidien or Parietex hernia mesh and later needed treatment for chronic pain, adhesions, infection, or revision surgery, here is who may qualify in MDL 3029 — the newer Medtronic/Covidien mesh litigation whose first bellwether trial has just begun.
Allegations Only · No Settlement Yet
This page describes ongoing litigation and an investigation. The statements below are unproven allegations. Covidien and Medtronic have not been found liable, no settlement has been finalized, and eligibility depends on the facts of each case. This page is informational and is not legal or medical advice.
What Is This About?
Were you implanted with a Covidien or Parietex hernia mesh — such as Parietex Composite, Parietex ProGrip, or Symbotex — and later diagnosed with chronic pain, adhesions, infection, a bowel obstruction, or a hernia recurrence that required a second surgery? If so, you may be eligible to speak with counsel about your legal options.The federal cases are consolidated in multidistrict litigation known as MDL 3029, In re: Covidien Hernia Mesh Products Liability Litigation (No. II), before Judge Patti B. Saris in the U.S. District Court for the District of Massachusetts. The "(No. II)" reflects that an earlier request to consolidate Covidien mesh cases was denied by the Judicial Panel on Multidistrict Litigation in 2020, when only about a dozen cases were on file; as the number of plaintiffs grew, the Panel granted centralization in 2022 and created MDL 3029.
The claims are allegations that have not been proven in court. The first bellwether trial began in July 2026, and no settlement has been reached.
Which Covidien Mesh Products Are Involved?
The litigation focuses on Covidien's polyester-based hernia mesh, most of which is sold under the Parietex brand. The products most often named include:• Parietex Composite mesh
• Parietex ProGrip (self-gripping) mesh
• Symbotex Composite Mesh
• Parietene mesh
Many of these devices combine a polyester base with an absorbable collagen barrier layer intended to reduce the mesh sticking to abdominal organs. Plaintiffs allege that this collagen coating resorbs too quickly, leaving bare polyester exposed against the bowel and internal tissue.
What Do the Lawsuits Allege?
Plaintiffs allege that the Covidien/Parietex mesh is defectively designed and that Covidien failed to adequately warn patients and surgeons of the risks. The core legal theories are:• Design defect: that the polyester construction and resorbable barrier are prone to premature breakdown, adhesion, and contraction.
• Failure to warn: that the company did not adequately disclose these risks to patients and physicians.
The alleged injuries include chronic and severe pain, infection, adhesions (the mesh adhering to bowel or organs), mesh migration, shrinkage or contraction, stiffening or degradation, bowel obstruction, hernia recurrence, and the need for revision or removal surgery. These remain unproven allegations.
Who May Qualify?
You may qualify to speak with counsel if you were implanted with a Covidien or Parietex hernia mesh device and later experienced a documented complication such as:• Chronic or severe pain
• Infection
• Adhesions or bowel obstruction
• Mesh migration, shrinkage, or contraction
• Hernia recurrence
• Revision or removal (explant) surgery
Eligibility depends on the specific device, your diagnosis, and the facts of your case. Helpful evidence includes your operative report, the implant sticker or device identification card, hospital and billing records, and records of any revision surgery. Statutes of limitations vary by state, so anyone considering a claim should consult an attorney promptly.
What Is the Current Status of the Litigation?
The MDL is in an active pretrial and first-trial posture. The first bellwether case, Patterson v. Covidien — which involves a Symbotex Composite Mesh device and alleges adhesions, bowel obstruction, and a bowel-resection surgery — was scheduled to go to trial before Judge Saris in July 2026 after being reset from an earlier date. A court-ordered mediation deadline in January 2026 passed without a global resolution. There is no settlement fund and no claim deadline at this time. Because a mass-tort MDL is a coordination of individual personal-injury suits (not a certified class action), any recovery would depend on the facts of each case.Frequently Asked Questions
Which Covidien hernia mesh products are in the litigation?
MDL 3029 involves Covidien's polyester-based hernia mesh, principally the Parietex family — including Parietex Composite, Parietex ProGrip, Symbotex Composite Mesh, and Parietene. Eligibility depends on the specific device implanted and the complications a patient experienced.
Who makes Covidien hernia mesh?
Covidien is a subsidiary of Medtronic, which acquired Covidien in 2015. The mesh is part of Medtronic's minimally invasive therapies business. Both Covidien and Medtronic entities are named in the litigation.
What injuries are alleged in the Covidien mesh lawsuits?
Plaintiffs allege the mesh caused chronic and severe pain, infection, adhesions, mesh migration, shrinkage or contraction, bowel obstruction, hernia recurrence, and the need for revision or removal surgery. They allege the resorbable collagen coating breaks down prematurely, exposing bare polyester to internal organs. These are unproven allegations.
Is there a Covidien hernia mesh settlement?
No. As of mid-2026 there is no global settlement. A court-ordered mediation deadline passed in January 2026 without a resolution, and the first bellwether trial (Patterson v. Covidien) began in July 2026. There is no settlement fund and no claim form at this time.
Related Mass Torts & Sources
• Bard / Davol hernia mesh lawsuit (MDL 2846) — the larger companion hernia mesh MDL, with a reported billion-dollar-plus settlement framework.• Bard PowerPort implanted-catheter lawsuit — another implanted-device MDL.
• Bair Hugger surgical warming device lawsuit (MDL 2666) — alleged surgical-site infection claims.
Primary sources: U.S. Judicial Panel on Multidistrict Litigation (JPML) pending-MDL statistics and transfer orders; the U.S. District Court for the District of Massachusetts MDL 3029 docket; and legal trade-press coverage of the Patterson bellwether trial.
Important Disclosures
This page is for general informational purposes and does not constitute medical or legal advice. You should consult a qualified attorney about your individual situation. OpenClassActions.com is not a law firm and is not a claims administrator, and this page does not create an attorney-client relationship.Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
